Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt

NCT06883123 is registered in ClinicalTrials.gov with Prairie Eye Center as lead sponsor.

NCT NCT06883123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06883123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt
Lead sponsor
Prairie Eye Center
Phase
Phase 4
Overall status
Recruiting
Start date
May 14, 2025
Completion date
April 1, 2026
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma